作者: V.C.G. Tjan-Heijnen , P.E. Postmus , A. Ardizzoni , Ch. Manegold , J. Burghouts
关键词:
摘要: Background CDE (cyclophosphamide, doxorubicin, etoposide) is one of the standard chemotherapy regimens in the treatment of small-cell lung cancer (SCLC), with myelosuppression …